Sabi E
Front Oncol. 2024; 14:1474267.
PMID: 39558949
PMC: 11570407.
DOI: 10.3389/fonc.2024.1474267.
Han L, Song T, Wang X, Luo Y, Gu C, Li X
Comput Struct Biotechnol J. 2024; 24:196-204.
PMID: 38495121
PMC: 10940798.
DOI: 10.1016/j.csbj.2024.02.021.
Miao Y, Konno Y, Wang B, Zhu L, Zhai T, Ihira K
J Transl Med. 2023; 21(1):151.
PMID: 36829176
PMC: 9960418.
DOI: 10.1186/s12967-023-03998-8.
Petkova V, Marinova D, Kyurkchiyan S, Stancheva G, Mekov E, Kachakova-Yordanova D
Medicine (Baltimore). 2022; 101(33):e30027.
PMID: 35984198
PMC: 9388044.
DOI: 10.1097/MD.0000000000030027.
Pavlikova L, Seres M, Breier A, Sulova Z
Cancers (Basel). 2022; 14(4).
PMID: 35205839
PMC: 8870231.
DOI: 10.3390/cancers14041090.
MicroRNA-21 Regulates Diametrically Opposed Biological Functions of Regulatory T Cells.
Sun J, Liu R, He X, Bian J, Zhao W, Shi W
Front Immunol. 2021; 12:766757.
PMID: 34858422
PMC: 8632542.
DOI: 10.3389/fimmu.2021.766757.
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs.
Prete A, Matrone A, Gambale C, Torregrossa L, Minaldi E, Romei C
Cancers (Basel). 2021; 13(13).
PMID: 34206867
PMC: 8267688.
DOI: 10.3390/cancers13133200.
MicroRNA Therapeutics in Cancer: Current Advances and Challenges.
Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N
Cancers (Basel). 2021; 13(11).
PMID: 34072348
PMC: 8198729.
DOI: 10.3390/cancers13112680.
Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer.
Le P, Romano G, Nana-Sinkam P, Acunzo M
Cancers (Basel). 2021; 13(6).
PMID: 33803619
PMC: 8003033.
DOI: 10.3390/cancers13061372.
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P, DAlessio S, Mortoglou M, Kraev I, Lange S
Int J Mol Sci. 2021; 22(3).
PMID: 33573274
PMC: 7866560.
DOI: 10.3390/ijms22031396.
A comparison of exosome purification methods using serum of Marek's disease virus (MDV)-vaccinated and -tumor-bearing chickens.
Neerukonda S, Egan N, Patria J, Assakhi I, Tavlarides-Hontz P, Modla S
Heliyon. 2020; 6(12):e05669.
PMID: 33336096
PMC: 7734234.
DOI: 10.1016/j.heliyon.2020.e05669.
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis.
Tabatabaeian H, Yang S, Tay Y
Cancers (Basel). 2020; 12(11).
PMID: 33158279
PMC: 7694276.
DOI: 10.3390/cancers12113264.
A Driver Never Works Alone-Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer.
Grzes M, Oron M, Staszczak Z, Jaiswar A, Nowak-Niezgoda M, Walerych D
Cancers (Basel). 2020; 12(6).
PMID: 32545208
PMC: 7353041.
DOI: 10.3390/cancers12061532.
Tissue microRNAs in non-small cell lung cancer detected with a new kind of liquid bead array detection system.
Zheng Y, Fei Y, Wang Z, Chen Y, Qiu C, Li F
J Transl Med. 2020; 18(1):108.
PMID: 32122370
PMC: 7053089.
DOI: 10.1186/s12967-020-02280-5.
The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
Valencia K, Erice O, Kostyrko K, Hausmann S, Guruceaga E, Tathireddy A
J Clin Invest. 2019; 130(4):1879-1895.
PMID: 31874105
PMC: 7108928.
DOI: 10.1172/JCI129012.
Stopping transformed cancer cell growth by rigidity sensing.
Yang B, Wolfenson H, Chung V, Nakazawa N, Liu S, Hu J
Nat Mater. 2019; 19(2):239-250.
PMID: 31659296
PMC: 7477912.
DOI: 10.1038/s41563-019-0507-0.
The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer.
Roncarati R, Lupini L, Shankaraiah R, Negrini M
Front Oncol. 2019; 9:988.
PMID: 31612113
PMC: 6777413.
DOI: 10.3389/fonc.2019.00988.
miRNA-Directed Regulation of the Main Signaling Pathways in Thyroid Cancer.
Ramirez-Moya J, Santisteban P
Front Endocrinol (Lausanne). 2019; 10:430.
PMID: 31312183
PMC: 6614345.
DOI: 10.3389/fendo.2019.00430.
miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
Zang C, Sun J, Liu W, Chu C, Jiang L, Ge R
Hum Cell. 2019; 32(4):428-436.
PMID: 31161410
DOI: 10.1007/s13577-019-00254-4.
Clinical significance of the expression of miRNA-21, miRNA-31 and miRNA-let7 in patients with lung cancer.
Wang S, Wang Z, Wang Q, Cui Y, Luo S
Saudi J Biol Sci. 2019; 26(4):777-781.
PMID: 31049003
PMC: 6486520.
DOI: 10.1016/j.sjbs.2018.12.009.